Natalie Danna, MD
Foot and Ankle Surgery · Baltimore, MDNPI 1528359569
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.4%), education and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 45.9% of the total.
Across 70 payments — averaging $191.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Supreme Orthopedic Systems, LLC$5K
- Stryker$2K
- Paragon 28, Inc.$127
- Pylant Medical$115
- International Rehabilitative Sciences, Inc$86
- plus $223 from 4 others
What the payments were for
- Speaking & faculty fees$5,00037%
- Travel & lodging$1,63512%
- Food & beverage$2,98422%
- Education$3,75628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 10 | $6,133 |
| Supreme Orthopedic Systems, LLC | 10 | $4,554 |
| Stryker(2 entities) | 35 | $2,136 |
| Paragon 28, Inc. | 4 | $127 |
| Pylant Medical | 1 | $115 |
| International Rehabilitative Sciences, Inc | 1 | $86 |
| Treace Medical Concepts, Inc. | 3 | $86 |
| Bioventus LLC | 3 | $50 |
| Embody, Inc. | 1 | $48 |
| Smith+Nephew | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPHECY$155
- MICA$150
- PROSTEP MICA$147
- AXSOS$131
- ALLOWRAP$128
How this compares
$13,376 in reported general payments places this provider in the 85th percentile of 182 foot and ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $108 |
| Oxycodone Hcl | 20 | $53 |
| Meloxicam | 19 | $25 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Baltimore
- Lew SchonBaltimore$752K
- Stuart MillerBaltimore$583K
- Patrick MaloneyBaltimore$262K
- Gregory GuytonBaltimore$216K
- Clifford JengBaltimore$74K
- Kyung SeoBaltimore$23K
- Richard SmithBaltimore$18K
- Jacob WisbeckBaltimore$17K
- Stephen JacobsenBaltimore$17K
- Brady WilliamsBaltimore$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.